Literature DB >> 16029354

Mycosis fungoides-associated follicular mucinosis under adalimumab.

S Dalle, B Balme, F Berger, S Hayette, L Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16029354     DOI： 10.1111/j.1365-2133.2005.06686.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

Review 1.  Is there truly a risk of lymphoma from biologic therapies?

Authors:  Erica Dommasch; Joel M Gelfand
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

2.  Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome.

Authors:  Laura Y McGirt; Christopher Thoburn; Allan Hess; Eric C Vonderheid
Journal:  Photodermatol Photoimmunol Photomed       Date:  2010-08       Impact factor: 3.135

3.  Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy.

Authors:  Maria Estela Martinez-Escala; Alba L Posligua; Heather Wickless; Audrey Rutherford; Kimberly A Sable; Belen Rubio-Gonzalez; Xiaolong A Zhou; Jason B Kaplan; Barbara Pro; Jaehyuk Choi; Christiane Querfeld; Steven T Rosen; Joan Guitart
Journal:  J Am Acad Dermatol       Date:  2018-01-04       Impact factor: 11.527

4.  Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.

Authors:  Hélène Théophile; Thierry Schaeverbeke; Ghada Miremont-Salamé; Abdelilah Abouelfath; Valentine Kahn; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

Review 5.  Mycosis fungoides and sezary syndrome: an update.

Authors:  Ellen J Kim; Julie Lin; Jacqueline M Junkins-Hopkins; Carmela C Vittorio; Alain H Rook
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

6.  A case for histologic verification of the diagnosis of atypical psoriasis before systemic therapy.

Authors:  Ruth Rohl; Daniel Bax; Shirley Schierer; Paul N Bogner; Francisco Hernandez-Ilizaliturri; Gyorgy Paragh
Journal:  JAAD Case Rep       Date:  2018-04-30

7.  The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-life Clinical Data.

Authors:  Iris Amitay-Laish; Emmanuella Guenova; Pablo L Ortiz-Romero; Cristina Vico-Alonso; Sima Rozati; Larisa J Geskin; Vasiliki Nikolaou; Evangelia Papadavid; Aviv Barzilai; Lev Pavlovsky; Elena Didkovsky; Hadas Prag Naveh; Oleg E Akilov; Emmilia Hodak
Journal:  Acta Derm Venereol       Date:  2020-09-30       Impact factor: 3.875

8.  Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab.

Authors:  Rosanne Ottevanger; Rutger C Melchers; Koen D Quint
Journal:  JAAD Case Rep       Date:  2022-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.